Saturday, June 6, 2026

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical trials are now being planned to test whether these drugs could help prevent breast cancer.

from Top Health News -- ScienceDaily https://ift.tt/K3yGbqt
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists discovered the brain doesn't make decisions the way we thought

A new study suggests the brain begins making decisions much earlier than scientists previously thought. Researchers found that even primary ...